A bit of a catch up on Protagonist Therapeutics. Hekumdai’s thread header referenced Protagonist’s IPO on the NASDAQ in August this year.
I note an article appearing this week on Seeking Alpha in which Protagonist (PTGX) is rated as one of five IPOs that led the way in 2016. Although there were no stag profits on listing day, since quiet period expiration ended in late September and analysts commenced coverage, the stock has done very nicely. This August market cap of AU$220m has since grown to AU$566m.
http://seekingalpha.com/article/4026275-5-biotech-ipos-lead-way-2016
A bit of a catch up on Protagonist Therapeutics. Hekumdai’s...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.025(1.98%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $324.1K | 254.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3702 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 27631 | 5 |
View Market Depth
| Last trade - 15.05pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |